This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient receiving alteplase (Activase) for treatment of acute ischemic stroke has a sudden ... (Read 47 times)

Davideckstein7

  • Hero Member
  • *****
  • Posts: 555
on: Jul 23, 2018
A patient receiving alteplase (Activase) for treatment of acute ischemic stroke has a sudden de-crease in level of consciousness. Which of the following conditions should the health care pro-vider suspect?
 
  a. Deep venous thrombosis
  b. Arterial occlusion
  c. Acute myocardial infarction
  d. Cerebral hemorrhage

Question 2

Which of the following patients would not be a candidate for drug therapy with a thrombolytic drug?
 
  a. A patient with a pulmonary embolism
  b. A patient with an acute myocardial infarction
  c. A patient with a confirmed ischemic cerebrovascular accident
  d. A pregnant patient with a deep venous thrombosis


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sailorcrescent

  • Sr. Member
  • ****
  • Posts: 334
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: D
Cerebral hemorrhage should be suspected in a patient who has a sudden decrease in level of con-sciousness with thrombolytic drug therapy.

Answer to Question 2

ANS: D
The use of thrombolytic drugs is generally contraindicated during pregnancy.


Davideckstein7

  • Member
  • Posts: 555
Reply 2 on: Jul 23, 2018
:D TYSM

Mochi

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

« previous next »
 

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Assessing Palpebral Conjunctiva, Patient Position Assessing Palpebral Conjunctiva, Patient Position
The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical inve
A computerized patient registration form used by offices with electronic health records. A computerized patient registration form used by offices with electronic health records.
Hemorrhagic and ischemic stroke. Hemorrhagic and ischemic stroke.
IgG after treatment with urea plus mercaptoethanol. IgG after treatment with urea plus mercaptoethanol.
Sign and symptoms of a patient with heart failure Sign and symptoms of a patient with heart failure
Video: Introduction to Human Immunodeficiency Virus (HIV)

For a complete list of videos, visit our video library